MyFinsight
Home
Blog
About
Back
Cash Flow
Cardio Diagnostics Holdings, Inc. (CDIO)
Cardio Diagnostics Holdings, Inc. (CDIO)
source: myfinsight.com
Net increase in cash
-$1,490,324
(-1172.08%↓ Y/Y)
Prepaid expenses and
other current assets
-$93,963
(57.44%↑ Y/Y)
Amortization
$51,158
(-63.20%↓ Y/Y)
Depreciation
$44,283
(-41.30%↓ Y/Y)
Stock-based compensation
expense
$24,352
(-60.33%↓ Y/Y)
Accounts payable and
accrued expenses
$7,112
(118.27%↑ Y/Y)
Accounts receivable
-$369
(93.51%↑ Y/Y)
Net cash used in
operating activities
-$1,342,364
(54.83%↑ Y/Y)
Net cash provided by
financing activities
-$101,171
(-103.17%↓ Y/Y)
Net cash used in
investing activities
-$46,789
(43.72%↑ Y/Y)
Canceled cashflow
$221,237
Net loss
-$1,501,468
(54.75%↑ Y/Y)
Payments of finance
agreement
$101,171
(-56.03%↓ Y/Y)
Patent costs incurred
$46,789
(-20.22%↓ Y/Y)
Lease liability
-$62,133
(46.74%↑ Y/Y)
Back